---
figid: PMC8381548__13045_2021_1138_Fig1_HTML
figtitle: Therapeutic strategies in METex14 skipping mutated non-small cell lung cancer
organisms:
- Homo sapiens
- Mus musculus
- Matthiola incana
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC8381548
filename: 13045_2021_1138_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8381548/figure/Fig1/
number: F1
caption: Schematic representation of the HGF/MET signaling pathway []. The binding
  of HGF to MET induces conformational changes, receptor dimerization, trans-phosphorylation
  of tyrosine residues in the catalytic domain of MET, and phosphorylation of tyrosine
  residues in the carboxyl-terminal tail. The phosphorylated tyrosine residues create
  docking sites for several adaptor molecules and kinase substrates. MET activation
  results in subsequent activation of signaling pathways that include ERK/MAPK, PI3K/AKT
  and STAT3, which mediate MET-dependent cell proliferation, survival, migration,
  and invasion. Capmatinib, tepotinib, and savolitinib block the phosphorylation of
  tyrosine residues
papertitle: Therapeutic strategies in METex14 skipping mutated non-small cell lung
  cancer.
reftext: Leylah M. Drusbosky, et al. J Hematol Oncol. 2021;14:129.
year: '2021'
doi: 10.1186/s13045-021-01138-7
journal_title: Journal of Hematology & Oncology
journal_nlm_ta: J Hematol Oncol
publisher_name: BioMed Central
keywords: NSCLC | MET Exon 14 skipping (METex14) | Tyrosine kinase inhibitor | Metastasis
automl_pathway: 0.9337935
figid_alias: PMC8381548__F1
figtype: Figure
redirect_from: /figures/PMC8381548__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8381548__13045_2021_1138_Fig1_HTML.html
  '@type': Dataset
  description: Schematic representation of the HGF/MET signaling pathway []. The binding
    of HGF to MET induces conformational changes, receptor dimerization, trans-phosphorylation
    of tyrosine residues in the catalytic domain of MET, and phosphorylation of tyrosine
    residues in the carboxyl-terminal tail. The phosphorylated tyrosine residues create
    docking sites for several adaptor molecules and kinase substrates. MET activation
    results in subsequent activation of signaling pathways that include ERK/MAPK,
    PI3K/AKT and STAT3, which mediate MET-dependent cell proliferation, survival,
    migration, and invasion. Capmatinib, tepotinib, and savolitinib block the phosphorylation
    of tyrosine residues
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GRB2
  - AKT1
  - AKT2
  - AKT3
  - HGF
  - IL6
  - SOS1
  - SRC
  - FGR
  - FYN
  - YES1
  - GAB1
  - PIGU
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - PLCG1
  - PLCG2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - PTPN11
  - XYLT2
  - SOS2
  - STAT3
  - Grb2
  - Akt1
  - Hgf
  - Met
  - Src
  - Gab1
  - Pik3r1
  - Ephb2
  - Mapk1
  - Shc1
  - Ptpn11
  - Stat3
  - drk
  - Akt
  - Src42A
  - Csk
  - Src64B
  - dos
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - MKP-4
  - p38b
  - rl
  - Erk7
  - sl
  - Shc
  - csw
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Sos
  - grb2b
  - src
  - gab1
  - ptpn11a
  - stat3
---
